2020 BIONIME Corporate Video

Find out more now our product : Click Here

Company Profile

Bionime was established in April 2003 with the goal of improving the lives of people with diabetes through better self-monitoring. Bionime is focused on designing and manufacturing accurate medical testing equipment. Our first product line started out with accurate blood glucose monitors that mimic the capabilities state-of-the-art devices usually found in healthcare research facilities. Our product line has since expanded into multiple different Self-Monitoring Blood Glucose (SMBG) Systems.

With the integration of top-tier scientific expertise, Bionime has successfully commercialized many patented technologies. This includes our unique Validus technology test strips which enables patients to receive accurate readings on-the-go.

Today Bionime operates in most major markets including Europe, the Middle East, Africa, the Americas, and Asia. Our products have received outstanding international recognition in clinical tests and by well-known journals. Our products continue to be distributed worldwide with great success.

Company History

2003:

Oct : The development of the first generation of blood glucose meter was completed.

Apr : BIONIME was founded at Dali City, Taichung County.

2004:

Dec : Set up Bionime Corporation.

Nov : Granted CE Certification and passed ISO13485 Certification.

2005:

Aug : Granted China SFDA of Rightest GM300 Aug.

Jun : Passed Taiwan GMP Certification Jun.

May : Launch Rightest GM300

Apr : Set up BIONIME GmbH Switzerland in Apr.

Jan : Granted FDA 510(K) of Rightest GM300

2006:

Feb : Set up BIONIME (ShenZhen) Co., Ltd.

2007:

Aug : Passed ISO 13485 and CMDCAS audit.

July : Passed TNO Certification.

Mar : Launch Rightest GM100.

2008:

Oct : In strategic alliance with Ypsomed, a Switzerland-based solution provider of injection system for diabetes treatment.

Sep : Granted FDA 510(K) of Rightest GM100, 110.

Aug : First shipment of ODM products.

Mar : Launch new Lancing Device to the market.

Feb : Set up BIONIME USA Corporation.

2010:

Dec : Become a public company and traded officially as a hi-tech company on the TWSE.

Sep : Granted the highest award of Taipei Biotech competition.

Aug : Approved to apply a high-tech list company by Industrial Development Bureau, Ministry of Economic Affairs.

Feb : Set up Bionime Australia Pty Limited.

2009:

Jul : Granted SFDA of RightestGM100, 110.

May : Launch of Rightest GM550 in Europe.

Apr : Pass KGMP audit.

Jan : Listed on Emerging Stock Market (#4737)

2011:

Dec : Bionime acquires the Innovation Award from Taiwan Ministry Economic Affair.

Sep : BIONIME has passed certification of OHSAS18001.

Jul : Acquisition land property for extending operation

Jul : Pass Taiwan AEO Certification

Mar : Strategic global cooperation with GE during term of Licensing Agreement in diabetes technology.

2012:

Dec : New Product “Mylife Unio” shipped to European Market

Jan : GE Selects Bionime to Launch Innovative Diabetes Solution

2013:

Oct : GM720 won the National Industrial Innovation Award

Sep : GD500 won National Invention and Creation Award

Sep : Pass Taiwan GMP certification

Mar : Mylife Unio Won Reddot Design Award

Mar : New Building & Factory completion

2014:

Dec : Received new patent in Germany for “Measuring Device for an Analyte”.

Jun : Members of the Diplomatic and Economic Representatives in Taiwan Visit Bionime for Exchange International Business and Bionime’s Competitive Advantages

Jan : GM720 won the Taiwan Excellence Award

2015:

Dec : Received capital injection by private placement of Dongbao Pharmaceutical Co., Ltd.

Apr : Obtained new patent in China is regarding "Insulin measuring pen with biological sensors".

Jan : Established subsidiary in Pingtan, China

2016:

Aug : Certified by Brazil's National Health Surveillance Agency and received ANVISA Certificate

Apr : Successfully obtained Good Manufacturing Practices (GMP) certification from the Ministry of Health and Welfare, Republic of China (Taiwan) for additional products including uric acid and cholesterol detections.

2017:

Oct : Meets ISO 13485:2016 certification of quality management systems for medical devices.

July : Launches Rightest CARE App, the blood glucose self-management App in Google Play and App Store.

July : GM700SB Bluetooth glucometer has been first released in Taiwan.

June : Releases new Rightest logo

Feb : GM700 Pro has won the Taiwan Excellence Award.

2018:

Nov : Rightest CARE Total Solution System has won the 2019 Taiwan Excellence Award

Mar : Established Malaysian subsidiary - Bionime (Malaysia) SDN BHD

Feb : Acquired ISO 27001:2013 information security management system certification

2019:

Feb : Bionime Indonesia established

Nov : Awarded the Taiwan Excellence Award (Rightest Blood Glucose Ecosystem)

2020:

Feb : Bionime Singapore established

2021:

May : Launches GM700 Pro 2 for easy data management and synchronization within hospitals